- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 182.92M sh |
| Shares Diluted | Q1 2026 · Mar 28, 2026 | 186.9M sh |
| Shares Diluted | Q1 2026 · Mar 29, 2025 | 166.12M sh |
| Dividends Paid | Q1 2026 · Mar 28, 2026 | $29.17K |
| Capex | Q1 2026 · Mar 28, 2026 | $1.3M |
| Capex | Q1 2026 · Mar 29, 2025 | $500.49K |
| Operating Cash Flow | Q1 2026 · Mar 28, 2026 | −$810.75K |
| Operating Cash Flow | Q1 2026 · Mar 29, 2025 | −$3.41M |
| Cash And Equivalents | Q1 2026 · Mar 28, 2026 | $34.1M |
| Stockholders Equity | Q1 2026 · Mar 28, 2026 | $60.83M |
| Stockholders Equity | Q1 2026 · Dec 27, 2025 | $64.12M |
| Current Liabilities | Q1 2026 · Mar 28, 2026 | $31.53M |
| Current Liabilities | Q1 2026 · Dec 27, 2025 | $33.99M |
| Total Liabilities | Q1 2026 · Mar 28, 2026 | $34.02M |
| Total Liabilities | Q1 2026 · Dec 27, 2025 | $36.72M |
| Current Assets | Q1 2026 · Mar 28, 2026 | $82.42M |
| Current Assets | Q1 2026 · Dec 27, 2025 | $91.81M |
| Total Assets | Q1 2026 · Mar 28, 2026 | $102.44M |
| Total Assets | Q1 2026 · Dec 27, 2025 | $108.39M |
| Eps Diluted | Q1 2026 · Mar 28, 2026 | −$0.02 |
| Eps Diluted | Q1 2026 · Mar 29, 2025 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 28, 2026 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 29, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 28, 2026 | $6.02M |
| Sga Expense | Q1 2026 · Mar 29, 2025 | $4.7M |
| Rd Expense | Q1 2026 · Mar 28, 2026 | $1.11M |
| Rd Expense restated | Q1 2026 · Mar 29, 2025 | $1.48M |
| Net Income | Q1 2026 · Mar 28, 2026 | −$3.75M |
| Net Income | Q1 2026 · Mar 29, 2025 | −$3.11M |
| Operating Income | Q1 2026 · Mar 28, 2026 | −$5.99M |
| Operating Income | Q1 2026 · Mar 29, 2025 | −$3.91M |
| Revenue | Q1 2026 · Mar 28, 2026 | $10.55M |
| Revenue | Q1 2026 · Mar 29, 2025 | $10.54M |